{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-26-000056","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.885263+00:00","generated_at":"2026-05-14T23:15:01.408267+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"West Pharmaceutical holds 2026 annual meeting; all proposals pass except shareholder chair proposal","bullets":["Eleven directors elected to one-year terms; all received majority support with >57M votes each.","Non-binding say-on-pay approved with 60.1M for, 3.8M against, 80K abstain.","Ratification of PwC as auditor for FY2026 passed with 58.5M for, 7.6M against.","Shareholder proposal for independent board chair policy not approved: 29.6M for, 34.2M against.","Total shares represented: 66.2M (91.83% of outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-26-000056","json":"https://secwatch.observer/filing/0000105770-26-000056.json","markdown":"https://secwatch.observer/filing/0000105770-26-000056.md","text":"https://secwatch.observer/filing/0000105770-26-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/wst-20260504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:15:01.408267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e3641659bf80d685e41aca0f5c25d24a226ddf4","claim":"WEST PHARMACEUTICAL SERVICES INC shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2026 at the 2026-05-04 meeting.","evidence_excerpt":"Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified as set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-04"}],"fact_type":"shareholder_vote"},{"claim_id":"3ff2b08147df01cfff4956c639ff39f3bea1bb3e","claim":"WEST PHARMACEUTICAL SERVICES INC shareholders rejected Shareholder proposal regarding an Independent Board Chair Policy at the 2026-05-04 meeting.","evidence_excerpt":"Proposal 4: The shareholder proposal regarding an Independent Board Chair Policy was not approved as set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2026-05-04"}],"fact_type":"shareholder_vote"},{"claim_id":"634c2b434c56d11e5a6be19432c4b7985e00b028","claim":"WEST PHARMACEUTICAL SERVICES INC shareholders approved Non-binding advisory vote to approve the compensation of the Company's named executive officers at the 2026-05-04 meeting.","evidence_excerpt":"Proposal 2: The non-binding advisory vote to approve the compensation of the Company's named executive officers was approved as set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-04"}],"fact_type":"shareholder_vote"},{"claim_id":"84d1bb5c6fce6e48acc7ef7251f6ab382b9b881f","claim":"WEST PHARMACEUTICAL SERVICES INC shareholders approved Election of eleven nominees as directors to serve until the 2027 Annual Meeting of Shareholders at the 2026-05-04 meeting.","evidence_excerpt":"Proposal 1: The eleven nominees, as set forth below and in the Company's 2026 Proxy Statement, were elected as directors, each to serve until the 2027 Annual Meeting of Shareholders.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}